Disease Screenings A 65-year-old female patient is seen your office for an annual physical examination. The patient states

Disease Screenings

A 65-year-old female patient is seen your office for an annual physical examination. The patient states that she has not seen a healthcare provider for the past 10 years because she has been feeling well. She has no past medical or surgical history. She reports no complaints. The patient is new to your practice. You completed a comprehensive history and physical examination on the patient. The patient states that she does not know her family history because she was adopted and never had a chance to meet or speak to her biological families. The history and physical exam are unremarkable.

Discuss the following:

1. Considering the patient age and gender, what preventive health and screenings would you consider for this patient based on the current guidelines?

Submission Instructions:

· Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial Hospital.  One of your tasks is applying applicable laws, policies, and procedures for ROI. For each scenario, describe the decision you render.  Answer the two questions that follow.

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in cases where traditional antipsychotic medications and psychosocial interventions have been ineffective? What are the challenges and opportunities in utilizing biomarkers of inflammation to aid in the early diagnosis and personalized treatment